Effects of Farinelli's Breathing Exercise in COPD Patients

Status Completed

Clinical Trial Summary

This study was to investigate the effect of Farinelli's breathing exercise on pulmonary function, respiratory muscle strength, aerobic capacity, impact of COPD questionnaires, cytokines, and oxidative stress in patients with Chronic Obstructive Pulmonary Disease (COPD).

Clinical Trial Description

Sixteen patients with COPD (GOLD I) with mild and moderate (GOLD II) severity aged 51 - 80 years old who visited at the outpatient examination room, Phramongkutklao Hospital divided into 2 groups; diaphragmatic breathing group (DB; n=8) and Farinelli's breathing group (FB; n=8). Participants in each group were administered to complete breathing exercise 5 times per week for 8 weeks. Physiological data and pulmonary function (FVC, FEV1, PEF, FEV1/FVC, FEF25-75%, MVV, VC, TV, IRV, ERV and IC), respiratory muscle strength (MIP and MEP), aerobic capacity (6-MWD and VO2max), impact of COPD questionnaire (mMRC and CAT), cytokine (TNF-α and IL-6), and oxidative stress (MDA) were analyzed during Pre- and Post-test. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04869033
Study type	Interventional
Source	Chulalongkorn University
Contact
Status	Completed
Phase	N/A
Start date	January 7, 2020
Completion date	August 27, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05980611` - Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Recruiting	`NCT00949195` - Pulmonary Arterial Pressure Response During Exercise	N/A
Completed	`NCT06128902` - The Effect of Home-Based Monitoring, Exercise Training	N/A
Completed	`NCT01475812` - Daily Activities Are Sufficient to Induce Dynamic Pulmonary Hyperinflation and Dyspnea in Chronic Obstructive Pulmonary Disease Patients	N/A
Completed	`NCT02157935` - Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease	Phase 3
Completed	`NCT01183052` - Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients	N/A
Withdrawn	`NCT00180622` - Markers for Chronic Obstructive Pulmonary Disease (COPD)
Completed	`NCT02099279` - Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation	N/A
Withdrawn	`NCT00361426` - EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients	N/A
Recruiting	`NCT03774238` - Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients	N/A
Enrolling by invitation	`NCT03851991` - The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD.	Phase 4